Division of Molecular Medicine and Gene Therapy
31 – 40 of 618
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
New sickle cell disease drug approved for use in England – here’s how voxelotor works
(2024) In The Conversation
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses
- Contribution to journal › Article
-
Mark
Reprogramming Stars #15 : Colliding Cellular Reprogramming Paths— An Interview with Dr. Stefan Stricker
- Contribution to journal › Debate/Note/Editorial
-
Mark
Osteopontin : A Key Multifaceted Regulator in Tumor Progression and Immunomodulation
- Contribution to journal › Scientific review
-
Mark
In-depth proteomic analysis and structural modelling of protein-protein interactions identify known and novel molecular binding partners for EMP3 in erythroid cells
- Contribution to journal › Published meeting abstract
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
- Contribution to journal › Article
-
Mark
How to manage patients with germline DDX41 variants : Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
- Contribution to journal › Article
-
Mark
Hematopoietic cells emerging from hemogenic endothelium exhibit lineage-specific oxidative stress responses
- Contribution to journal › Article
-
Mark
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response
- Contribution to journal › Article
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
- Contribution to journal › Article
